Mortality and risk factors for cardiovascular and non-cardiovascular disease in Japanese with impaired glucose metabolism

Mortality and risk factors for cardiovascular and non-cardiovascular disease in Japanese with impaired glucose metabolism - The Hiroshima Study on Glucose Metabolism and Cardiovascular Diseases (Hiroshima GMCVD)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000036648

Enrollment

19248

Registered

2019-05-07

Start date

2019-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus Hypertension Cardiovascular disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Participants were recruited after undergoing general health examinations at the Health Management and Promotion Center of the Hiroshima Atomic Bomb Casualty Council. 2.They agreed to undergo the 75-g oral glucose tolerance test.

Exclusion criteria

Exclusion criteria: Participants were on treatment for type 1 or type 2 diabetes.

Design outcomes

Primary

Measure	Time frame
All-cause and cardiovascular death	—

Secondary

Measure	Time frame
1.Incidence of diabetes 2.Incidence of hypertension 3.Renal dysfunction 4.Proteinuria 5.Atrial fibrillation 6.Dyslipidemia 7.Hyperuricemia 8.White matter lesions 9.Common carotid artery measurements 10.Serum N-terminal pro B-type natriuretic peptide level 11.Cardio-ankle vascular index 12.Ankle-brachial index	—

Countries

Japan

Contacts

Public ContactTomomi Fujita

Hiroshima Atomic Bomb Casualty Council Health Management and Promotion Center

t-ikyoku@gentaikyo.or.jp082-243-2451

Outcome results